¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦11Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2022) 2ÀÏÂ÷ : 2022-09-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦11Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2022) 2ÀÏÂ÷ : 2022-09-16
±³À°ÀÏÀÚ : 2022-09-16
±³À°Àå¼Ò : ¿©Àǵµ ÄÜ·¡µå È£ÅÚ  
±³À°ÁÖÁ¦ : Á¦11Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2022) 2ÀÏÂ÷
ÁÖÃÖ±â°ü : Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ
´ã´çÀÚ : ICoLA2022 »ç¹«±¹
¿¬¶ôó : 02-2285-2507  
À̸ÞÀÏ : secretariat@icola2022.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 22 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 140,000¿ø      
ºñ°í Àü¹®ÀÇ, ±³¼ö : »çÀüµî·Ï 120,000¿ø / ÇöÀåµî·Ï 140,000¿øÀüÀÓÀÇ, Àü°øÀÇ,Çлý µî : »çÀüµî·Ï 60,000¿ø / 70,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-16 Room 1 08:00~08:30 Benefits of insulin sensitizer Atherosclerosis & Stroke  Jung-hyun Noh(Inje University, Korea) 
Åä·Ð 09-16 Room 1 08:30~08:40 Discussion  () 
±³À°½Ã°£ 09-16 Room 2 08:00~08:30 Management of uric acid in hypertensive patients: Role of losartan  Hack-Lyoung Kim(Seoul National University, Korea) 
Åä·Ð 09-16 Room 2 08:30~08:40 Discussion  () 
±³À°½Ã°£ 09-16 Room 1,2,3 09:00~09:40 Target discovery & drug development for atherosclerosis in 2020  Sekar Kathiresan(Verve therapeutics, USA) 
È޽Ġ09-16  09:40~09:45 Break  () 
±³À°½Ã°£ 09-16 Room 1 09:45~10:05 Novel mechanisms for lipogenesis regulation  Gina Lee(University of California Irvine, USA) 
±³À°½Ã°£ 09-16 Room 1 10:05~10:25 Local & systemic effect of organ fat deposition  Sung Hee Choi(Seoul National University, Korea) 
±³À°½Ã°£ 09-16 Room 1 10:25~10:45 Liver & adipose tissue in atherosclerosis  Ji Young Lee(University of Connecticut, USA) 
Åä·Ð 09-16 Room 1 10:45~11:10 Discussion  () 
±³À°½Ã°£ 09-16 Room 2 09:45~10:05 Validation of metabolic targets in adipose tissue for ASCVD  Mete Civelek(University of Virginia, USA) 
±³À°½Ã°£ 09-16 Room 2 10:05~10:25 Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis & paracrine fibrotic signalling  Judith Sluimer(Maastricht University, Netherlands) 
±³À°½Ã°£ 09-16 Room 2 10:25~10:45 Recent single cell findings for novel immune & immune-like cell actions in atherosclerosis  Jae-Hoon Choi(Hanyang University, Korea) 
Åä·Ð 09-16 Room 2 10:45~11:10 Discussion  () 
±³À°½Ã°£ 09-16 Room 3 09:45~10:05 What is the role of a polygenic risk score in CV risk assessment?  Amit Khera(Verve Therapeutics, USA) 
±³À°½Ã°£ 09-16 Room 3 10:05~10:25 Refinement of CV risk in current "very high" & "high" risk groups  Hyeon Chang Kim(Yonsei University, Korea) 
±³À°½Ã°£ 09-16 Room 3 10:25~10:45 Risk stratification according to age s in new prevention guidelines  Kwang-il Kim(Seoul National University, Korea) 
Åä·Ð 09-16 Room 3 10:45~11:10 Discussion  () 
±³À°½Ã°£ 09-16 Room 4 09:45~10:05 Exercise & inflammation in atherosclerosis  Matthias Nahrendorf(Harvard Medical School, USA) 
±³À°½Ã°£ 09-16 Room 4 10:05~10:25 Effect of different diets on circulating lipoproteins  Frank M. Sacks(Harvard Medical School, USA) 
±³À°½Ã°£ 09-16 Room 4 10:25~10:45 Update on heart-healthy diet: studies in the past decade  Min-Jeong Shin(Korea University, Korea) 
Åä·Ð 09-16  10:45~11:10 Discussion  () 
È޽Ġ09-16  11:15~11:25 Coffee Break  () 
±âŸ 09-16  11:25~11:30 Opening Address  () 
±³À°½Ã°£ 09-16 Room 1,2,3 11:30~12:00 Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders  Brian Tomlinson(Macau University, China) 
±³À°½Ã°£ 09-16 Room 1 12:00~12:30 Is combination therapy recommended for high risk ASCVD patients? : When and Why combination therapy is needed  Jong-Chan Youn(The Catholic University of Korea, Korea) 
Åä·Ð 09-16 Room 1 12:30~12:40 Discussion  () 
±³À°½Ã°£ 09-16 Room 2 12:00~12:30 Cutting edge care of Pitavastatin with Ezetimibe combination therapy  Junhwa Hong(Eulji University, Korea) 
Åä·Ð 09-16 Room 2 12:30~12:40 Discussion  () 
±³À°½Ã°£ 09-16 Room 3 12:00~12:30 What are the optimal treatment options of dyslipidemia management for your patients? based on LDL-C lowering continuum  So-Yeon Choi(Ajou University, Korea) 
Åä·Ð 09-16 Room 3 12:30~12:40 Discussion  () 
±³À°½Ã°£ 09-16 Room 1,2,3 12:55~13:35 Senescence & vascular smooth muscle cell plasticity  Martin Bennett(University of Cambridge, UK) 
±³À°½Ã°£ 09-16 Room 1 13:35~13:55 Current evidence on risk stratifying factors in Koreans  Ji Hye Huh(Hallym University, Korea) 
±³À°½Ã°£ 09-16 Room 1 13:55~14:15 How much different event risk do Koreans have compared to European descendants?  Song Vogue Ahn(Ewha Womans University, Korea) 
±³À°½Ã°£ 09-16 Room 1 14:15~14:35 How to of low risk individuals to avoid pharmacotherpy?  Hack-Lyoung Kim(Seoul National University, Korea) 
Åä·Ð 09-16 Room 1 14:35~15:00 Discussion  () 
±³À°½Ã°£ 09-16 Room 2 13:35~13:55 Customized functional food based on big data  Jiyoung Kim(Seoul National University, Korea) 
±³À°½Ã°£ 09-16 Room 2 13:55~14:15 Customized prevention of metabolic disease in Koreans using omics technology  Min Joo Kim(Hannam University, Korea) 
±³À°½Ã°£ 09-16 Room 2 14:15~14:35 Healthcare program using digital health device  Young In Kim(Noom Inc., Korea) 
Åä·Ð 09-16 Room 2 14:35~15:00 Discussion  () 
±³À°½Ã°£ 09-16 Room 3 13:35~13:55 Macrophage diversity in inflammation & homeostasis  Ichiro Manabe(Chiba University, Japan) 
±³À°½Ã°£ 09-16 Room 3 13:55~14:15 Inflammation & hematopoiesis in atherosclerosis  Katey Rayner(University of Ottawa, Canada) 
±³À°½Ã°£ 09-16 Room 3 14:15~14:35 Immune cell activities in aortic aneurysm  Seung-Jun Lee(Yonsei University, Korea) 
Åä·Ð 09-16 Room 3 14:35~15:00 Discussion  () 
±³À°½Ã°£ 09-16 Room 4 13:35~13:55 Dyslipidaemia - new treatments for ApoC3 and ANGPTL3  Brain Tomlinson(The Chinese University of Hong Kong) 
±³À°½Ã°£ 09-16 Room 4 13:55~14:15 New treatment targets beyond LDL-C in dyslipidaemias  Alberico Catapano(University of Milan, Italy) 
±³À°½Ã°£ 09-16 Room 4 14:15~14:35 Novel Selective PPARa Modulator Pemafibrate for Dyslipidemia  Shizuya Yamashita(Rinku General Medical Center, Japan) 
Åä·Ð 09-16  14:35~15:00 Discussion  () 
È޽Ġ09-16  15:05~15:15 Break  () 
±³À°½Ã°£ 09-16 Room 1 16:15~16:35 Korean evidence on target LDL-C levels  Min Kyong Moon(Seoul National University, Korea) 
±³À°½Ã°£ 09-16 Room 1 16:35~16:55 Are current Western LDL-C targets for each risk s cost-effective in Koreans?  Sang-Hyun Kim(Seoul National University, Korea) 
±³À°½Ã°£ 09-16 Room 1 16:55~17:15 When is clinically appropriate to start anti-PCSK9 Abs?  Chang-Wook Nam(Keimyung University, Korea) 
Åä·Ð 09-16 Room 1 17:15~17:40 Discussion  () 
±³À°½Ã°£ 09-16 Room 2 16:20~16:35 Regulation of Macrophage Activation and Differentiation in Atherosclerosis  Sung Ho Park(Ulsan National Institute of Science and Technology (UNIST), Korea) 
±³À°½Ã°£ 09-16 Room 2 16:35~16:50 Prospect of Artificial Intelligence Based on Electronic Medical Records  Hun-Sung Kim(Catholic University of Korea, Korea) 
±³À°½Ã°£ 09-16 Room 2 16:50~17:05 Intravital Two-photon Imaging of Dynamic Alteration of Hepatic Lipid Droplets in Fasted and Refed State  Philhan Kim(Korea Advanced Institute of Science and Technology (KAIST), Korea) 
±³À°½Ã°£ 09-16 Room 2 17:05~17:20 Statin Therapy and the Risk of Osteoporotic Fractures in Patients With Metabolic Syndrome: A Nested Case-Control Study  Kyoung Jin Kim(Korea University, Korea) 
±³À°½Ã°£ 09-16 Room 2 17:20~17:35 Metabolism and Health Impacts of Dietary Sugars  Cholsoon Jang(University of California Irvine, USA) 
Åä·Ð 09-16 Room 2 17:35~17:45 Q&A  () 
±³À°½Ã°£ 09-16 Room 3 16:15~16:35 Aging as risk factor & therapeutic target in atherosclerosis  Sungha Park(Yonsei University, Korea) 
±³À°½Ã°£ 09-16 Room 3 16:35~16:55 New target genes & molecules for vascular aging  Tohru Minamino(Juntendo University, Japan) 
±³À°½Ã°£ 09-16 Room 3 16:55~17:15 What effect do cardiovascular medications & diet have on vascular aging?  Kenichi Tsujita(Kumamoto University, Japan) 
Åä·Ð 09-16 Room 3 17:15~17:40 Discussion  () 
±³À°½Ã°£ 09-16 Room 4 16:15~16:35 Impact of risk factors & medications on COVID-19 outcomes  In Sook Kang(Ewha Womens University, Korea) 
±³À°½Ã°£ 09-16 Room 4 16:35~16:55 Effect of COVID-19 on dyslipidemia & vascular disease  Edward Janus(University of Melbourne, Australia) 
±³À°½Ã°£ 09-16 Room 4 16:55~17:15 Benefit & harm of COVID-19 vaccines in ASCVD  Ta-Chen Su(National Taiwan University, Taiwan) 
Åä·Ð 09-16 Room 4 17:15~17:40 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦11Â÷ International Congress on Lipid & Atherosclerosis (ICoLA 2022) 2ÀÏÂ÷ : 2022-09-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °í½Å´ëÇб³º¹À½º´¿ø Á¤Çü¿Ü°úÇб³½Ç ÅëÁõ¿¬±¸ ½ÉÆ÷Áö¾ö : 2022-09-17
´ÙÀ½±Û ¼­¿ï¾Æ»êº´¿ø ¿Â¶óÀÎ(9¿ù16ÀÏ) ±Ý¿äÁý´ãȸ(ÈÄ°¢ÀÇ ±â´É Àå¾Ö) : 2022-09-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 105 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 5 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 5 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 5 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 1 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 1 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 1 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 1 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 1 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20880 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20879 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷